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ABSTRACT
These studies were conducted to elucidate the regional analgesic effect that is
observed clinically after treatment of orthopedic disorders with application of
extracorporeal shock waves in horses. Regional analgesia after treatment with
extracorporeal shock waves presents a concern because it may eliminate protective
limiting mechanisms and may place equine athletes with predisposing lesions at risk of
sustaining career- or life-ending injuries.
Direct percutaneous application of non-focused extracorporeal shock waves to
palmar digital nerves in the pastern area of horses resulted in decreased sensory nerve
conduction velocities compared with untreated control nerves at 3, 7, and 35 days after
treatment. Transmission electron microscopy revealed distinct morphological changes
consisting of extensive separation and disruption between the different layers of the
myelin sheath in large- to medium-sized myelinated axons of treated palmar digital
nerves.
Treatment of selected areas of the metacarpus in horses with non-focused
extracorporeal shock waves failed to identify a regional analgesic effect when cutaneous
sensation was assessed by comparing the nociceptive threshold (limb withdrawal reflex
latency, LWRL) between treated and non-treated areas after stimulation with a focused
light source. The LWRL responses in all horses were comparable in treated and control
areas over time with a significant decrease noted at most sites and time points compared
with baseline values.
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CHAPTER 1
GENERAL INTRODUCTION
Musculoskeletal disorders are the most prevalent cause of wastage in
Thoroughbred racehorses and other performance breeds. Wastage is a term used to
describe either the loss of horses from conception to adulthood, or the days lost by equine
athletes due to inability to train or compete (Olivier et al. 1997). Musculoskeletal
disorders reportedly have a major financial impact on the equine industry, both in terms
of loss of athletic performance of the horse and expenses for diagnostics and treatments
(Kobluk et al. 1990).
Extracorporeal shock wave therapy (ESWT) represents a new treatment modality
used to treat selected orthopedic injuries in horses and appears to be gaining considerable
interest and acceptance among veterinarians, trainers and horse owners. Extracorporeal
shock waves (ESW) were first used in humans in the 1980’s to fragment renal and
urinary bladder stones (Chaussy et al. 1980). Since 1985, concretions in other organs
such as gallbladder, bile duct, pancreas and salivary glands have been treated with ESW
(Iro et al. 1989; Iro et al. 1992; Sauerbruch et al. 1986; Sauerbruch et al. 1987). In the
past ten years, ESW were also successfully used to treat a variety of orthopedic disorders
in humans, such as fracture non-unions, pseudarthroses, osteochondrosis and various
tendinopathies (Haupt 1997). Based on these encouraging results, ESW were adapted to
treat orthopedic disorders in horses.
Extracorporeal shock waves are acoustic pressure gradient waves with a rise time
of 5 to 10 nanoseconds (ns) to a peak pressure of up to 100 megapascals (MPa), followed
by a rapid fall to negative pressure, before returning to baseline in a total pulse time of
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approximately 300 ns (Sturtevant 1996). Two fundamentally different techniques are
used to generate ESW, focused and non-focused generators (McClure and Merritt 2003).
Focused ESW generators initiate pressure waves within a fluid medium. These waves are
focused by reflection within the generator and directed toward a focal point in the body
of the patient (Sturtevant 1996). Non-focused ESW or radial pressure waves are
generated by mechanical concussion and transmitted into the patient’s body by use of a
hand-held applicator. They are characterized by lower wave energies, a slower rise time
than focused ESW, and a negative component that is approximately of the same order as
the positive component (McClure and Merritt 2003). There is no focusing mechanism
and the maximum energy generated by non-focused ESW is observed at the applicatorpatient skin interface and declines rapidly in proportion to the distance from the
generator. Both types of ESW generators are currently used to treat orthopedic disorders
in horses (McClure and Merritt 2003).
Although the exact mechanism by which ESW exert their effects in tissues is not
fully understood, a transient local analgesic effect within shock wave-treated areas has
been observed in humans and horses (Haupt 1997; McClure and Merritt 2003; McClure
et al. 2003). Several painful soft tissue syndromes in humans, such as tennis elbow and
golfer’s elbow, are currently treated using low energy ESW with considerable success
(Haupt 1997). Local analgesia occurring after ESWT application is most likely
independent of any other beneficial effect on tissue healing and could place equine
athletes at risk of sustaining career-ending or life-threatening injuries, such as condylar
fractures of the third metacarpus or metatarsus or breakdown of the suspensory apparatus
of the fetlock, if exercised under the influence of local analgesia. These safety concerns
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have been recognized by the equine industry and have recently resulted in development
of regulations regarding the use of ESWT prior to training and competition by racing
jurisdictions and the Federation Equine International (FEI). Due to the potentially
catastrophic and fatal consequences of an analgesic effect that eliminates self-limiting
protective mechanisms after ESWT application, side effects of this new treatment
modality should be thoroughly investigated prior to widespread, uncontrolled application
in performance horses.
The global hypothesis of this thesis was that ESW cause a transient local
analgesic effect when applied to the distal limb in horses and that this effect is at least
partially mediated by alterations in function and morphology of peripheral nerves within
treated areas. To address these concerns, two studies were conducted.
The purpose of the first study was to identify functional changes in superficial
peripheral nerves by measuring sensory nerve conduction velocities (SNCV) in palmar
digital nerves directly treated with non-focused ESW compared with non-treated control
nerves at different times after application. Additionally, it was intended to determine any
relationship between changes in SNCV and morphologic changes in treated nerve
segments by histology and transmission electron microscopy (TEM). It was hypothesized
that SNCV in ESW-treated nerve segments would decrease, compared with non-treated
control nerves, and that characteristic nerve lesions would be present after ESW
application.
The purpose of the second study was to determine if a local cutaneous analgesic
effect occurs after non-focused ESW application to the dorsal aspect of the third
metacarpus in horses by using a standardized pain model and by comparing treated
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versus non-treated control legs within the same animal. Additionally, it was intended to
determine the interval of time of altered nociception in treated legs after ESW
application. It was hypothesized that horses would exhibit an absent or delayed limb
withdrawal reflex latency (LWRL) in ESW-treated legs in response to a painful stimulus
with a focused light source. It was further hypothesized that the response to the pain
stimulus would not be different in treated and non-treated limbs after attenuation of the
local analgesic effect.
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CHAPTER 2
REVIEW OF LITERATURE
2.1

Significance of Lameness in Performance Horses
Lameness represents an indication of a structural or functional disorder in the

horse’s limbs or back that can be observed while the animal is standing or in motion
(Stashak 2002a). Causes for lameness include trauma, congenital or acquired
conformational anomalies, infections, metabolic disturbances, circulatory and nervous
disorders, and various combinations of these (Stashak 2002a). Diagnosis and treatment of
disorders causing lameness in horses are associated with considerable cost and have a
major impact on the equine industry, both in terms of loss of athletic performance and
amount of money spent for diagnostics and treatments (Ross et al. 1998).
A survey in a mixed horse population reported that common risk factors for
lameness include athletic activity, housing in small operations, and the male or malecastrated gender (Ross et al. 1998). For racehorses, a large amount of information is
collected in data bases and multivariate techniques enable the investigation of individual
risk factors for musculoskeletal injury and lameness, thereby allowing a more
sophisticated approach to study the complex interaction between many variables. Risk
factors identified for musculoskeletal injury in Thoroughbreds include age, sex, shoe
type, track type and surface, track condition, season, intensity of racing and training, days
since the last race, and type of racing activity (flat racing, hurdle or steeple chase)
performed (Bailey et al. 1998; Estberg et al. 1996; Hernandez et al. 2001; Kane et al.
1996; Mohammed et al. 1991). The properties of facilities for training and competition
also appear to have a major influence on the occurrence of musculoskeletal injuries in

5

other performance horses. A study in racing Standardbreds showed that increasing the
banking of the turns of the racetrack caused a significantly lower incidence of
musculoskeletal injuries and lameness (Evans and Walsh 1997).
Wastage is a term used to describe both the phenomenon of lost performance in
horses from conception to adulthood due to death or injuries (i.e. they never perform), or
days lost due to inability to train or compete (Olivier et al. 1997). Multiple surveys in
populations of Thoroughbred racehorses (Jeffcott et al. 1982; Kobluk et al. 1990; Lindner
and Dingerkus 1993; Olivier et al. 1997; Rossdale et al. 1985; von Herzog and Lindner
1992) and Standardbreds (Physick-Sheard 1986a; Physick-Sheard 1986b; Physick-Sheard
and Russell 1986) consistently identified lameness as the most prevalent cause for
wastage. With 72.1% and 67.6%, respectively, the percentage of training days lost
attributable to disorders causing lameness was comparable between Thoroughbred
racehorses in South Africa (Olivier et al. 1997) and England (Jeffcott et al. 1982). In a
survey of Thoroughbred racehorses in Germany, musculoskeletal problems were
responsible for 55.3% of the horses retiring from racing (von Herzog and Lindner 1992).
A study in a different German racing Thoroughbred population attributed 57% of the
wastage occurring due to lameness (Lindner and Dingerkus 1993). A survey within a
Thoroughbred racehorse population in the United States reported an estimated 44% of
horses having a musculoskeletal problem preventing them from training or racing
anytime during the survey period, and an additional 32% of horses having a
musculoskeletal problem requiring alterations in their training and racing schedules
(Kobluk et al. 1990). During a single racing season in England, Jeffcott et al. (1982)
observed the majority of causes for lameness in a population of 164 racehorses in the
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forelimb (70%), with lesions in the foot (15.4%), dorsal metacarpus (15.4%), fetlock
(15.0%), and carpus (12.6%) being the most prevalent sites of lameness. In 21 cases
(8.5%), the site of lameness could not be determined (Jeffcott et al. 1982). These findings
are in agreement with another survey from England by Rossdale et al. (1985) who
detected a comparable distribution of the sites of lameness in 198 racing Thoroughbreds
over two seasons (Rossdale et al. 1985). However, the percentage of cases where the site
of the lameness could not be localized (31.2%) was considerably greater than in Jeffcott’s
survey.
In daily practice, the origin or the site of lameness in a horse is often suspected by
a process of elimination of other (common) sites, but the exact origin may actually
remain unknown (Rossdale et al. 1985). Many conditions that cause lameness respond
favorably to restricted exercise and/or administration of non-steroidal anti-inflammatory
drugs (NSAIDs), and precise localization of the cause of lameness is not attempted due to
the time and costs associated with a thorough lameness examination including
intrasynovial and peripheral nerve blocks, and diagnostic imaging (Rossdale et al. 1985).
Lameness is an important economical factor in performance horses, not only due
to costs arising from diagnostics and treatments, but also due to the loss of generated
income (money won). Lameness disorders therefore represent a challenge to the equine
practitioner who wants to provide pain relief, reinstitute athletic use of the horse, and
minimize economic loss, while at the same time operate within ethical and regulatory
constraints of modern competition. This generates a growing interest in economical,
alternative treatment modalities that appear to result in an improved and accelerated
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healing process and shorter convalescence periods, such as extracorporeal shock wave
therapy (ESWT).
2.2

Extracorporeal Shock Waves

2.2.1

Characteristics of Extracorporeal Shock Waves
Extracorporeal shock waves (ESW) are acoustic pressure gradient waves that are

created by a generator and propagated into the patient’s body where they exert their
effects on tissues. They are characterized by positive pressures of up to 100 megapascals
(MPa), followed by a rapid fall to negative pressures of 5-10 MPa. One MPa corresponds
to approximately 10 times the atmospheric pressure. Extracorporeal shock waves build up
very rapidly with a rise time of 30-120 nsec, and their pulse duration is approximately
300 to 500 nsec (Sturtevant 1996). Shock waves are differentiated from other acoustic
waves (e.g. ultrasound waves) by their lower frequencies, their lower tissue absorption,
and the absence of thermal effects within tissues. Therapeutic ESW travel nearly
unchanged through fluids and soft tissues of the body and exert their effects at sites
where there is a change in acoustic impedance along their path. Energy is released at
these interfaces of different impedance values, and this creates compression and shear
loads on the surface of the material with greater impedance. Rapid interaction between
compression and shear forces results in a process referred to as cavitation. Microscopic
gas bubbles are built up on the surface of the material with greater impedance and the
collapse of these bubbles creates a small jet of liquid (fast flow) that causes high local
stresses. Cavitation effects are believed to be responsible for the effects of ESW in tissues
(Sturtevant 1996).
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Although the exact mechanism of how ESW exert their effects in tissues is poorly
understood, four consecutive reaction phases are postulated to occur in the body (Haupt
1997). In the physical phase, extracellular cavitations, ionization of molecules and an
increase in cell membrane permeability occur as a direct effect of ESW. The subsequent
physical-chemical phase consists of an interaction between diffusible radicals and
biomolecules released from ESW-stimulated cells. This results in the chemical phase
characterized by intracellular reactions and molecular changes in the cells. The biological
phase is established if the changes occurring in the chemical phase persist (Haupt 1997).
Two fundamentally different types of shock waves (focused and non-focused
shock waves or radial pressure waves) are used for extracorporeal shock wave therapy
(ESWT) in humans and animals (McClure and Merritt 2003). Following their generation
in a fluid medium, focused shock waves are concentrated (focused) and directed by
reflection at target zones in the patient’s body (Sturtevant 1996). Focused ESW are
created and focused from a wide arc so that at the site of actual wave generation, the
amount of energy dispersed to the periphery is minimal (Sturtevant 1996). Via a focusing
mechanism, each shock wave is directed toward a clearly defined point within the body
of the patient; thus the wave energy concentrated at this point is extremely high. This
point is referred to as the focal point and its location within the patient can be changed by
adjusting the energy output (voltage) of the generator or by adjusting the focusing
mechanism (Sturtevant 1996). In stationary focused ESW generators, diagnostic imaging
techniques, such as fluoroscopy, radiography or ultrasound, are used to exactly localize
the focal point (Schnewlin and Lischer 2001). This minimizes surrounding soft tissue and
organ damage because the maximal (therapeutic) wave energy is reached only at the focal
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point (Schnewlin and Lischer 2001; Sturtevant 1996). The energy that focused ESW
exert at the focal point is expressed as energy flux density and is recorded in energy per
surface area units (mJ/mm2). The more focused the emitted shock waves, the greater is
the energy flux density achieved at the focal point (Sturtevant 1996).
Focused shock waves are generated by initiating a pressure wave within a fluid
medium. Three different mechanisms are currently used to generate focused shock
waves. Piezoelectric systems utilize a crystalline material that, when stimulated with high
voltage electricity can expand or contract and initiate a pressure wave in surrounding
fluid. Electromagnetic systems have coils that create opposing magnetic fields when an
electric current is applied to them, causing a submerged membrane to move and generate
a pressure wave in the surrounding fluid medium. Electrohydraulic systems create a
plasma bubble via generation of a high voltage spark. Expansion of the plasma bubble
compresses the surrounding fluid medium, thereby creating a pressure wave. Although all
three mechanisms have different waveforms and energy characteristics, they all generate
ESW that appear to be sufficiently intense to exert tissue effects at the focal point
(Sturtevant 1996). Recently, portable electrohydraulic and piezoelectric systems have
been introduced into the veterinary market to treat musculoskeletal disorders in horses. In
these units, focused ESW are generated and reflected in handheld probes that are applied
to the limb or body of the horse.
Non-focused extracorporeal shock waves or radial pressure waves are created by
mechanical concussion and appear as expanding wave fronts that rapidly attenuate after
their generation (Ammendolia et al. 2001; McClure and Merritt 2003). Compared to
focused ESW, they are characterized by lower wave energies, a slower rise time, and a
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negative component that is of the same magnitude as the preceding positive component
(McClure and Merritt 2003). Non-focused ESW are not reflected or redirected toward a
focal point in the patient’s body and their wave energy declines rapidly in proportion to
the distance from the site of their generation. Non-focused ESW are transmitted up to 35
mm into the patient’s body (Ammendolia et al. 2001). They are generated by
transforming kinetic energy from an accelerated piston within a handheld applicator to
mechanical force. The applicator is applied to the patient’s skin surface for treatment.
Since non-focused ESW differ considerably form focused ESW, the term “shock wave”
may be inappropriate to describe them (Schnewlin and Lischer 2001). However,
beneficial effects in treatment of various orthopedic disorders in man (Gremion et al.
2001; Lohrer et al. 2001a; Lohrer et al. 2001b) and horses (Boening et al. 2000; Palmer
2002) with non-focused ESW have been reported. Due to their affordability and their
small size, portable units for non-focused ESWT have gained substantial popularity in
equine practice.
2.2.2 Lithotripsy
Lithotripsy was the first reported medical application of ESW. The literal
meaning of the term lithotripsy is “the act of breaking stones” (Adams and Senior 1999).
Initially, mechanical devices were developed in human medicine to crush or fragment
urinary concretions (uroliths) in the urinary bladder. These devices reduced uroliths to
multiple fragments that could be flushed through a cystoscope sheath or pass the urethra
without causing further obstruction (Adams and Senior 1999). The major drawback of
these mechanical lithotripsy systems was their size, which precluded their use in more
confined locations such as the urethra, ureter and renal pelvis. Their use in smaller
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patients such as children, cats and small dogs was impractical, and these patients instead
had to undergo open surgery procedures for the removal of urinary calculi (Senior 1984).
In the early 1970’s, Haeusler and Kiefer demonstrated that shock waves are
capable of disintegrating human renal stones in vitro (Haeusler and Kiefer 1971).
Subsequently, electrohydraulic shock-wave lithotripsy (EHL) was developed to fragment
uroliths in people without the need for large crushing devices (Adams and Senior 1999).
The EHL electrode generates a spark in the fluid surrounding the concretion. Generation
and subsequent disappearance of this spark results in large pulse pressures (shock waves),
which are absorbed by the concretion and lead to its disintegration (Watson 1970).
Because the electrode wire used for EHL is quite small, this technique allows lithotripsy
in less accessible anatomical locations, such as the urethra, ureter and renal pelvis
(Adams and Senior 1999; Mitchell and Kerr 1977; Raney 1975). Electrohydraulic
lithotripsy has also been used in veterinary medicine to disintegrate cystic calculi in dogs
(Senior 1984), and cystic (Eustace and Hunt 1988; MacHarg et al. 1985) and ureteral
(Rodger et al. 1995) calculi in horses.
The development of extracorporeal shock wave lithotripsy (ESWL) in the early
1980’s was considered a major breakthrough in the treatment of uroliths, because it
allows disintegration of stones in the upper urinary tract non-invasively from outside the
body (Chaussy et al. 1980; Chaussy et al. 1982; Lingeman et al. 1987). In ESWL, shock
waves are generated in the fluid medium of a wave generator and then transmitted
percutaneously through the soft tissues of the patient to the urolith. Wave transmission
into the body can be accomplished by submerging the patient in a water bath, or by using
a fluid- or gel-filled cushion that is placed against the patient’s skin over the target area.
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The latter is referred to as second or third generation or “dry” lithotripsy (Auge and
Preminger 2002). Repeatedly administered shock waves cause disintegration of the
urolith into small fragments that can be passed through the distal urinary tract. Currently,
ESWL is considered to be the treatment of choice for 70 to 80% of people with uroliths
(Chaussy and Fuchs 1989; Lingeman et al. 1987). An additional 25% of patients with
more complex stones in the upper urinary tract can be treated with lithotripsy in
combination with endourological procedures and do not have to undergo invasive open
surgery (Chaussy and Fuchs 1989).
Extracorporeal shock wave lithotripsy has also been used to treat nephroliths and
ureteroliths in dogs (Adams and Senior 1999; Block et al. 1996). In animals, ESWL must
be performed under general anesthesia to allow for adequate positioning and analgesia.
Approximately 30% of dogs treated with ESWL require two treatments to disintegrate
uroliths into fragments that are sufficiently small to traverse the ureter (Adams and
Senior 1999). These success rates are comparable with those of ESWL of nephroliths in
people where first treatment success rates of 76% to 99% have been reported (Psihamis et
al. 1992; Wilson and Preminger 1990).
Although ESWL of nephroliths was at first not believed to cause damage to the
kidney (Chaussy and Schmidt 1984), studies in people, dogs, and minipigs showed that it
causes intrarenal hemorrhage (Hill et al. 1990; Koga et al. 1996; Lingeman et al. 1989;
Newman et al. 1987). The severity of damage caused by ESW depends on dose (voltage
and number of shock waves) and frequency (number of shock waves per second) of the
treatment (Lingeman et al. 1989; Newman et al. 1987). A study revealed that renal
damage occurs mainly in the tubules and peritubular capillaries, and that the glomerular
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filtration rate and renal blood flow return to pre-treatment levels by one week after
ESWL (Hill et al. 1990).
After the successful introduction of ESWL for destruction of uroliths, concretions
in other organs of human patients such as gallbladder, bile duct, pancreas and salivary
glands have also been successfully treated with ESWL (Iro et al. 1989; Iro et al. 1992;
Sauerbruch et al. 1986; Sauerbruch et al. 1987).
2.2.3

Important Animal Models
Prior to the clinical application of ESW for the treatment of musculoskeletal

disorders their effects on tissues were extensively investigated in animal models. Initial
studies in piglets revealed a dose-dependent stimulation of wound healing in irradiated
and non-irradiated split-thickness skin wounds (Haupt and Chvapil 1990). These findings
led to the hypothesis that fracture healing might also be enhanced by shock waves.
Delius et al. (1995) observed periosteal detachment and extensive subperiosteal
hemorrhage in specimens collected from rabbits immediately after a single application of
focused shock waves to the stifle. Intense apposition of new lamellar bone and
considerable cortical thickening of the bone were observed in samples that were obtained
several weeks after treatment (Delius et al. 1995). Comparable observations were made in
a dog model by Ikeda et al. (1999) after shock wave application to the femur (Ikeda et al.
1999). Radiographic, histological and biochemical findings in a rat model suggested that
fracture healing was stimulated by ESW (Haupt et al. 1990). These findings were
corroborated in a canine model (Johannes et al. 1994), where all ESW-treated dogs
demonstrated a radiographically evident bony union of an osteotomized radius at twelve
weeks after a single treatment with focused ESW, compared with only one bony union
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that was observed in the untreated control group (Johannes et al. 1994). In a sheep
osteotomy model, treatment with focused ESW resulted in a smaller fracture gap and
enhanced periosteal and endosteal bone apposition on radiographs (Ekkernkamp et al.
1991). The radiographic findings in that study were confirmed by histological and
fluorescence microscopic analysis where accelerated apposition of stable lamellar bone
was observed (Ekkernkamp et al. 1991). In a rabbit osteotomy model, ESW application
resulted in such exuberant callus formation that the overall process of fracture healing
and bone remodeling was actually delayed (McCormack et al. 1996).
Shock wave-induced bone formation and remodeling is believed to be caused by
microfractures within the bone which act as local stimulators of bone remodeling
(Kaulesar Sukul et al. 1993; Valchanou and Michailov 1991). In a dog femoral
osteotomy model, hemorrhage, detachment of the periosteum, and small fractures on the
inner surface of the cortex were observed immediately after application of 500 or more
focused ESW (Ikeda et al. 1999). Initial studies conducted in horses, however, failed to
identify the presence of microfractures after treatment with focused ESW (McClure et al.
2000).
In an attempt to investigate the effect of ESW on equine bone, McClure et al.
(2000) applied 1,000 pulses of focused ESW dorsally to metacarpal and metatarsal bones
of horses under general anesthesia. All animals were euthanatized immediately after
treatment and treated and non-treated bones were evaluated macroscopically and
microscopically. In agreement with studies in smaller species (Delius et al. 1995; Ikeda et
al. 1999), ESW induced subperiosteal and endosteal hemorrhage at the application sites.
However, no microfractures and no other lesions in skin, tendons, suspensory ligaments
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and associated neurovascular structures of treated limbs were observed (McClure et al.
2000). A recent histomorphometrical ex-vivo study in third metacarpal and metatarsal
bone segments from horses revealed small but significant effects of ESW on the
appearance of microcracks in cortical bone (Da Costa Gomez et al. 2004). Whereas
application of focused ESW resulted in an increased density of bone microcracks
compared with untreated bone segments, an increase in microcrack length was observed
after non-focused ESW application (Da Costa Gomez et al. 2004).
Because of the proximity of many ESWT application sites to synovial joints,
possible side effects of ESW on articular cartilage were investigated in a rabbit model by
Vaeterlein et al. (2000). No significant radiographic, gross or histological pathological
changes were observed in physeal and articular cartilage after ESW application to the
femoral condyle in growing rabbits (Vaeterlein et al. 2000).
2.2.4

Orthopedic Applications in Humans
2.2.4.1

Pseudarthrosis

In people, 0.5 to 10% of long bone fractures may exhibit delayed or insufficient
healing and may ultimately result in pseudarthrosis (Bischof and Kinzl 2000). Success
rates for treatment of pseudarthrosis with ESWT have been reported to vary between
21% and 97% (Haist 1995; Haupt 1997; Ikeda et al. 1999; Schleeberger and Senge 1992).
In one study, the patients were differentiated with regard to hypertrophic versus atrophic
forms of pseudarthrosis based on radiographic criteria. While the majority of patients
with hypertrophic pseudarthrosis revealed complete healing, healing after ESWT was
rarely observed in patients with atrophic pseudarthrosis (Haist 1995). Complications
following ESWT for pseudarthroses include transient local pain, petechial subcutaneous
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bleeding and hematomas. These were observed in up to 4% of human patients (Haupt
1997).
2.2.4.2

Hip Endoprosthesis

Implant instability has been identified as the most prevalent cause of failure in hip
endoprosthesis (Ahnfeldt et al. 1990). This condition is usually addressed by replacement
of the loose prosthesis. Extracorporeal shock waves have been investigated for their
potential use to loosen the bone cement surrounding the implant in order to facilitate
removal of the old prosthesis prior to replacement (Karpman et al. 1987; May et al. 1990;
Weinstein et al. 1988). However, these attempts were unsuccessful and the failure was
explained by the similar acoustic properties of bone and bone cement (Delius 1995;
Weinstein et al. 1988).
2.2.4.3

Osteochondrosis

One investigator treated people with osteochondrosis dissecans of the stifle and
talus with ESWT and observed re-attachment of fragments to the parent bone in several
cases (Schleeberger 1995). Other ESW applications with promising results have also
been performed in patients with Koehler’s Disease, Perthes’ Disease or OsgoodSchlatter’s Disease (Haist and von Keitz-Steeger 1995; Schleeberger 1995). To date,
however, it appears that the use of ESW for the treatment of osteochondrosis has to be
considered experimental (Haupt 1997).
2.2.4.4

Calcific Tendonitis

Calcium deposits in the soft tissues of the shoulder represent a common and often
incidental radiographic finding in people. Deposits develop most often in the
supraspinatus tendon and can be detected in 2 to 20% of people without symptoms of
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shoulder pain (Bosworth 1941). However, significantly more patients with shoulder pain
(up to 50%) have calcium deposits (Bosworth 1941). Spontaneous resolution of the
calcium deposits and associated clinical signs has been observed in up to 100% of people
with acute shoulder pain (Harmon 1958). However, chronic recurrent shoulder pain is
often associated with persistent discomfort and calcium deposits on radiographs.
Conventional treatment for calcific tendonitis includes physical therapy, NSAIDs,
radiotherapy, steroid infiltration, needling (breaking up calcium deposits with
hypodermic needles), and arthroscopic or open surgical procedures (Haupt 1997). In one
study, twenty patients with severe shoulder pain and calcium deposits of at least 1 cm
diameter were treated with focused ESW. Twelve weeks later, seven patients showed
complete radiographic disappearance of the deposits, whereas partial disintegration was
observed in five patients. Six patients were completely pain-free, eight were substantially
improved and only one patient experienced clinical deterioration (Loew et al. 1995). Two
other case series of patients with calcific tendonitis reported complete resolution of
shoulder pain or substantial clinical improvement in 73% and 83% of patients treated
with ESWT, respectively (Haupt and Katzmeier 1995; Rompe et al. 1995). The specific
mechanism of action of ESW on the calcium deposits is unknown. One investigator
postulated that resorption of the calcium deposits within the tendon occurs and that this
process is preceded by mechanical breakdown and by reactive local neovascularization
(Loew et al. 1995). The potential of ESW to induce neovascularization has recently been
demonstrated in a canine model where new capillary-formation was observed at the
tendon-bone interface of Achilles tendon specimens after application of low energy ESW
(Wang et al. 2002).
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2.2.4.5

Soft Tissue Pain Syndromes

Painful tendinopathies in people, such as tennis elbow (epicondylitis humeri
radialis), golfer’s elbow (epicondylitis humeri ulnaris), or shoulder pain (periarthritis
humero-scapularis) have historically been treated with combinations of immobilization,
physical therapy, radiotherapy and local steroid injections with variable success rates
(Haupt 1997). Surgical treatments, such as the release of the common forearm extensor
origin in severe cases of tennis elbow, are usually restricted to patients that are
unresponsive to non-surgical treatment, but these procedures appear to yield good to
excellent results (Haupt 1997; Verhaar 1994).
Dahmen et al. (1992) were the first to use ESWT to treat patients with soft tissue
pain in proximity to bones. A variety of more than 30 different syndromes were treated in
512 patients for whom surgery was originally intended. Fifty-two percent of the cases
experienced excellent results, 28% showed substantial improvement and only 3%
ultimately required surgical procedures (Dahmen et al. 1992). Haist and von KeitzSteeger (1995, 1996) reported success rates of 86% and 74% for treatment of tennis
elbow and shoulder pain with focused ESW, respectively (Haist and von Keitz-Steeger
1995; Haist and von Keitz-Steeger 1996). In another investigation, focused ESW were
used to treat 150 people with tennis elbow that had undergone unsuccessful conservative
treatment attempts for at least the previous three months (Rompe et al. 1995). A success
rate of 84% in a population of patients that would otherwise have required surgical
treatment was observed (Rompe et al. 1995). Lohrer et al. (2001) treated 55 patients with
tennis elbow with up to three applications of non-focused ESW. Inclusion in this study
required at least two unsuccessful conservative treatment attempts during the six months
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previously and a clinical indication for surgical treatment. Fifty-six percent of the patients
that were previously limited in their activities revealed resolution of all symptoms after
12 months (Lohrer et al. 2001a).
The exact mechanism how ESW exert their reversible analgesic effect in soft
tissue pain syndromes still needs to be elucidated. Clinically, a biphasic analgesic
response is observed in people (Ogden and Ogden 2002). An immediate relief appears to
be followed by a return of the pain at three to four days after treatment with ESW and
then a second gradual improvement over the ensuing 3 to 4 weeks occurs (Ogden and
Ogden 2002).
Haist and von Keitz-Steeger (1995) proposed three hypotheses for how ESW
could induce local analgesia: 1) ESW induce cell membrane damage and non-functional
nociceptors are subsequently unable to build up a membrane potential to transmit pain
signals; 2) the nociceptors are over-stimulated by ESW and emit high frequency impulses
that are modulated by a gate control mechanism; and 3) ESW-induced free radicals
change the cellular environment and induce the release of unknown local painsuppressing substances (Haist and von Keitz-Steeger 1995). The gate control hypothesis
is somewhat corroborated by the results of an ex-vivo study where electromyographic
measurements from an isolated frog sciatic nerve in an organ bath revealed that
approximately 95% of shock waves applied to the nerve were able to induce action
potentials that were lower in amplitude but similar in shape to compound action
potentials evoked by direct electrical stimulation (Schelling et al. 1994). With increasing
dose and frequency of application, ESW are capable of inducing considerable
morphological damage in peripheral nervous tissues. In one study, marked structural
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abnormalities were observed in peripheral nerves of mice after application of high-energy
ESW to the calf muscles (Smits et al. 1993).
2.2.5. Orthopedic Applications in Veterinary Medicine
In the late 1990’s, ESW were introduced into veterinary medicine to treat
musculoskeletal disorders in horses (McCarrol 1999). To date, however, no controlled
studies for the use of this new treatment modality in horses have been published. Various
case series reporting encouraging results for the treatment of orthopedic disorders in
horses have been presented at scientific meetings (Boening et al. 2000; Crowe et al. 2002;
McCarrol 1999; Palmer 2002; Scheuch et al. 2000).
Horses are usually treated with two to three treatments of medium to high-energy
ESW administered at three-week intervals (Schnewlin and Lischer 2001). The hair over
the target area is clipped and the shock waves are transmitted into the horse’s body
through a fluid- or gel-filled cushion (focused ESW) or by placing the applicator with the
piston against the horse’s skin (non-focused ESW). Use of a coupling gel is usually
necessary to optimize shock wave transmission and to minimize energy loss.
Treatment with both non-focused and focused ESW can be associated with
considerable irritation and may be resented by the animals. Sedatives and manual
restraint (e.g. a nose twitch) are often necessary to administer the ESWT regimen in
standing horses (Boening et al. 2000; Palmer 2002). Occasionally, peripheral nerve
blocks are placed prior to ESWT application, or treatment is performed under general
anesthesia (McCarrol and McClure 2000).
Non-focusing shock wave generators initially gained substantial popularity in
equine practice due to their small size and their affordability. The comparison between
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non-focused (radial) and focused ESW generators and their therapeutic effects appears to
be somewhat difficult due to the different characteristics of the shock waves they
generate. Recently, portable electrohydraulic and piezoelectric systems have been
introduced into the veterinary market to treat musculoskeletal disorders in horses.
2.2.5.1

Suspensory Desmitis and Flexor Tendon Injuries

Lesions at the origin of the suspensory ligament account for approximately 5% of
forelimb lameness in performance horses (Dyson 1992). Pain at the suspensory origin can
be caused by suspensory ligament desmitis, torn Sharpey’s fibers at the insertion of the
ligament, or even avulsion fractures of the origin (Bertone 2002). Flexor tendonitis,
particularly tendonitis of the superficial digital flexor (SDF) tendon, is a common cause
of lameness in racehorses and other performance horses (McIlwraith 2002). Lesions in
these structures range from minor tearing of fibers to complete rupture of the tendon.
Similar to suspensory desmitis, flexor tendonitis results in a high morbidity with a
prolonged recovery period (McIlwraith 2002).
In one study, 30 horses with chronic suspensory ligament desmitis were treated
with three applications of non-focused ESWT at two- to four-week intervals. Four weeks
after the last treatment, 16 horses were free of lameness and 9 horses had improved at
least one lameness grade (Boening et al. 2000). Donati et al. (2001) treated a total of 202
performance horses with acute and chronic flexor tendon injuries or supensory ligament
desmitis with focused ESWT under ultrasonographic control. Up to three treatments were
administered to the horses standing under chemical restraint. After an average follow-up
of 30 months, a complete resolution of clinical signs was observed in 87% of horses
(Donati et al. 2001).
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2.2.5.2

Dorsal Metacarpal Disease

Periostitis and stress fractures of the dorsal surface of the third metacarpal bone
constitute a spectrum of diseases that are commonly observed in young fast-gaited horses
of two to three years of age (Bertone 2002). Although the greatest incidence is observed
in Thoroughbred racehorses, it can also affect young Quarter Horses and occasionally
racing Standardbreds. This disease complex is referred to as dorsal metacarpal disease
(DMD) and is believed to occur due to a failure of the adaptive response of the third
metacarpal bone to altered biomechanical stresses arising from high-speed training and
racing (Bertone 2002).
Palmer (2002) treated 50 Thoroughbred racehorses with DMD with non-focused
ESWT. All horses meeting clinical and radiographic inclusion criteria for the study had
been treated unsuccessfully for at least two months previously with combinations of stall
rest, restricted exercise, percutaneous periosteal scraping, osteostixis, and NSAIDs. After
three treatments at three-week intervals, 40 horses (80%) resumed speed-work consisting
of breezing and racing without lameness or other clinical signs associated with DMD
(Palmer 2002). In another study, 10 horses with dorsal or palmar metacarpal cortical
stress fractures were treated one to three times with focused ESW applied under
ultrasonographic control. Ninety days after the last treatment, eight horses (80%) had
returned to racing or training and six (60%) were pain-free and/or revealed radiographic
signs of fracture healing (Scheuch et al. 2000).
2.2.5.3

Degenerative Joint Disease

Degenerative joint disease (DJD) is the common end-stage of a large variety of
joint disorders and is characterized by progressive deterioration of articular cartilage

23

accompanied by changes in the subchondral bone and the soft tissue components of the
joint (McIlwraith 2002). Pain and functional restriction associated with DJD account for
a majority of clinically observed lameness disorders in horses.
McCarrol and McClure (2000) treated 75 horses with DJD of the distal intertarsal
and tarsometatarsal joints (bone spavin) with one treatment of 2,000 pulses of
electrohydraulic focused ESW. All horses were treated under general anesthesia and
under fluoroscopic control. After ninety days, 59 horses (80%) had improved at least one
lameness grade and 13 (18%) were completely sound. In all horses, no significant
changes in radiographic findings (e.g. ankylosis of the distal tarsal joints) were observed
compared with radiographs obtained prior to treatment. The investigators believed that
clinical improvement in these horses resulted either from an ESW-induced analgesic
effect or from altered shock absorption properties of the distal tarsal bones due to
adaptive remodeling after treatment (McCarrol and McClure 2000).
2.2.5.4

Navicular Disease

Navicular disease represents one of the most common and controversial causes of
intermittent forelimb lameness in horses between four and 15 years of age (Ackerman et
al. 1977; Stashak 2002b). It has been estimated that navicular disease accounts for onethird of all cases of chronic forelimb lameness in horses (Colles 1982).
Non-surgical treatment for navicular disease includes various types of corrective
shoeing in combination with NSAIDs, medication with hemorheologic agents such as
isoxsuprine hydrochloride, pentoxifylline and propentofylline, injection of corticosteroids
and/or sodium hyaluronate in the distal interphalangeal joints or in the podotrochlear
bursa, intramuscular injection of polysulfated glycosaminoglycans, and oral
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supplementation of glucosamine hydrochloride and sodium chondroitin sulfate (Stashak
2002b). Surgical treatment is usually reserved for cases that are unresponsive to nonsurgical treatment. Currently, palmar digital neurectomy represents the most commonly
performed surgical treatment for navicular syndrome. This procedure desensitizes the
caudal one-third to one-half of the palmar foot region and the sole extending dorsally to
the toe (Stashak 2002b).
Garcia Lineiro and Echezarreta (2001) treated 15 horses with navicular disease
with five treatments of 3,000 pulses of non-focused ESW at one week-intervals. All
horses included in the study had clinical signs for over six months, presented with at least
a grade 3/5 lameness, and had previously undergone unsuccessful medical and/or surgical
treatment attempts. The ESW treatment was applied percutaneously over the palmar
digital nerves and over the palmar surface of the navicular bone. In all animals,
improvement of the lameness was observed after the third treatment and the lameness had
completely resolved in all horses after the fifth treatment. All horses in the study
remained sound for of at least 60 days (Garcia Lineiro and Echezzareta 2001). Another
study reported on the treatment of 26 horses with one application of electrohydraulic
focused ESW under general anesthesia. Complete resolution of lameness was observed in
all horses after 6 months (Baer et al. 2001). In another investigation where lower doses of
focused ESW were utilized, a substantially lower success rate was reported for the
treatment of navicular disease (Scheuch et al. 2000).
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2.3

Morphology and Function of Peripheral Nerves

2.3.1

Anatomy and Physiology
The axons of peripheral nerves are surrounded by three different layers of

connective tissue (Kimura 1989a). The endoneurium provides the supporting structure
around individual axons within the nerve fascicles. The perineurium consists of
collagenous tissue that binds each fascicle with elastic fibers and mesothelial cells. This
layer also provides a diffusion barrier to regulate intrafascicular fluid (Ross and Reith
1969). The epineurium is composed of collagen tissue, elastic fibers and fatty tissue and
binds individual fascicles together (Kimura 1989a).
Peripheral nerves contain myelinated and unmyelinated fibers. Multiple inherent
factors determine whether or not myelination of an axon will occur (Kimura 1989a). In
myelinated fibers, the surface membrane of a Schwann cell (axolemma) spirals around
the axon to form the myelin sheath. Each myelinated axon has its own Schwann cells,
which regulate the myelin volume and thereby the thickness of the myelin sheath (Smith
et al. 1982). The nodes of Ranvier, located at junctions between adjacent Schwann cells
along the axon, represent gaps that are not insulated by Schwann cell processes. In
myelinated nerve fibers, action potentials propagate from one node of Ranvier to another
and the rate of propagation is approximately proportional to the fiber diameter. The
spacing of the Schwann cells at the time of myelination determines the internodal
distance. As the nerve grows in length during development, the internodal distance must
increase because Schwann cells are unable to proliferate. Thus, the fibers myelinated
early achieve larger diameters and wider spacing of the nodes of Ranvier (Vizoso and
Young 1948).
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In contrast to myelinated axons, several unmyelinated fibers share Schwann cells
that give rise to multiple separate processes, each surrounding one axon (Gamble and
Eames 1964). In unmyelinated fibers, conduction velocity varies in proportion to the
square root of fiber diameter (Kimura 1989a).
Axons of nerve cells have electrical properties common to all excitable cells in
the body. The inside of the nerve fiber is negatively charged with a transmembrane
steady-state potential that measures from -20 to -100 mV depending on the exact location
(Kimura 1989a). The somatic membrane of the nerve cell body has less polarization (-70
mV) than the axon (-90 mV). Application of a weak current to a nerve causes negative
charges to accumulate outside the axon membrane, making the inside of the cell
relatively more positive (cathodal depolarization). Under the positive pole (anode), the
negative charges tend to leave the membrane surface, making the inside of the cell
relatively more negative (anodal hyperpolarization). After about 10 to 30 mV of
depolarization, the membrane reaches the critical level for initiation of an action potential
with a consistent response, regardless of the kind of stimulus or its magnitude. An action
potential initiated along the course of an axon propagates in both directions from its point
of origin. Intracellular current flows from the active area to the adjacent negatively
charged inactive area. An opposing current flows through the extracellular fluid from the
inactive to the active region of the axon. This local current depolarizes inactive regions
on both sides of the active area. Once it reaches the critical level, an action potential
generates a new local current further distally or proximally along the axon (Kimura
1989a).
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In myelinated fibers, action potentials can only occur at the nodes of Ranvier.
This results in a local current jumping from one node to the next (saltatory conduction)
instead of a continuous propagation as it is observed in unmyelinated fibers (Kimura
1989a).
Various factors affect the time necessary for the generation of action potentials,
which in turn determines the conduction velocity of an axon. Rapid propagation and fast
conduction velocity result from faster rates of action potential generation, increased
current flow along the axons, lower depolarization thresholds of the axonal membrane,
and higher temperature which facilitates depolarization by increasing sodium
conductance toward the intracellular fluid (Kimura 1989a). The longitudinal resistance of
the axoplasm tends to inhibit the flow of local current. In myelinated axons, the
capacitance and conductance of the internodal membrane have the same effect resulting
in loss of current before it reaches the next node of Ranvier. This increases the time
required to depolarize the adjacent nodal membrane, thereby decreasing conduction
velocity. Both internodal capacitance and conductance decrease with myelin thickness.
For a fixed axonal diameter, conduction velocity increases with myelin thickness only up
to a certain point. An increase in myelin thickness has two opposing effects on
conduction velocity; a larger axoplasmic resistance on one hand, and smaller membrane
conductance and capacitance on the other (Waxman 1980). Damaged nerve fibers with
demyelinated or partially remyelinated nerve fibers have an increased internodal
capacitance and conductance because of their thin myelin sheath. More local current is
lost to charge the capacitance and by leakage through the internodal membrane before
reaching the next node of Ranvier (Kimura 1989a). Thus, demyelinated axons

28

characteristically have conduction failure, decreased conduction velocities, and temporal
dispersion (Waxman 1980).
Conduction abnormalities in myelinated axons do not necessarily imply the
presence of demyelination, but can also result from compression. The decreased fiber
diameter in this case should actually facilitate conduction. Concomitant increase in
resistance in the axoplasm, however, more than offsets this effect by delaying the flow of
current to the next node of Ranvier (Kimura 1989a).
Peripheral nerves contain different groups of nerve fibers with different
conduction velocities. Each class of nerve fibers is represented by a characteristic peak in
the compound action potential (CAP) elicited by supramaximal electric stimulation
(Kimura 1989b). A-fibers represent afferent or efferent myelinated somatic axons. In
sensory nerves, they are subdivided in four groups (I to IV), whereas in efferent muscle
nerves they are subdivided into alpha and gamma motoneurons, according to their fiber
diameter. Cutaneous somatic nerves contain myelinated alpha and delta A-fibers and are
also subdivided according to their diameter. The efferent unmyelinated C-fibers consist
of the efferent postganglionic axons of autonomic nerves and the small afferent axons of
the dorsal root and peripheral nerves. Several C-fibers share a single Schwann cell, unlike
A- and B-fibers which are individually insulated. This and the absence of the myelin
sheath allow histological identification of the C-fibers (Kimura 1989a).
2.3.2

Classification of Nerve Injuries
Three degrees of peripheral nerve injuries have been described (Seddon 1943).

Neuropraxia represents bruising or conduction loss without actual structural damage to
the axon. Complete recovery usually takes place within days or weeks after removal of
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the cause. The conduction velocity of the nerve, if initially slowed because of associated
demyelination, returns to normal with repair of the myelin sheath. Mechanical factors
have been identified as the major factor for the development of neuropraxia (Kimura
1989b); however, short term changes in nerve conduction can also be induced by anoxia
secondary to ischemia (Lewis et al. 1931). In axonotmesis, axonal damage results in the
loss of continuity and Wallerian degeneration of the distal segment of the nerve fiber
(Seddon 1943). Conduction block occurs immediately at the site of injury, followed by an
irreversible loss of excitability, first at the neuromuscular junction, then at the distal
nerve segment. The time course of Wallerian degeneration varies considerably among
different species, but it does generally not occur until 4 or 5 days after acute interruption
of nerve continuity (Gilliatt and Taylor 1959). Functional recovery depends on
regeneration of nerve fibers and can take months or years due to their slow growth rate (1
to 3 mm per day). Neurotmesis is referred to as an injury that separates the entire nerve
and disrupts supporting connective tissue structures. Functional recovery after
neurotmesis depends on whether the perineurium and the architecture of the nerve sheath
were severed at the time of injury (Kimura 1989a).
2.3.3 Principles of Nerve Conduction Studies
Measurement of conduction characteristics represents a simple and reliable testing
method of peripheral nerve function. With adequate standardization, this method allows
not only identification of a lesion in a nerve, but also precise localization of the site of
maximal involvement. Electrical stimulation of a nerve is used to initiate an impulse that
travels along motor, sensory, or mixed nerve fibers. Assessment of conduction
characteristics depends on the analysis of evoked compound action potentials (CAP) that
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are recorded either on the muscle if evaluating motor fibers or from the nerve itself if
evaluating sensory nerve fibers (Kimura 1989b). Electrical stimulation is used in most
clinical studies; however, tactile stimulation has also been shown to elicit recordable
nerve action potentials (Buchthal 1965). In an ex-vivo study using frog sciatic nerves in
organ baths, approximately 95% of shock waves that were applied to the nerve were able
to induce action potentials that were lower in amplitude but similar in shape to the
compound action potentials evoked by electrical stimulation in conduction studies
(Schelling et al. 1994).
Surface electrodes or needle electrodes can be used for electrical stimulation of a
nerve. Needle electrodes placed subcutaneously close to the nerve require much less
current to elicit the same response in the nerve than surface electrodes applied to the skin
(Kimura 1989b). Stimulating electrodes consist of a cathode (negative pole) and an anode
(positive pole). Monopolar or bipolar electrical stimulation of the nerve can be
performed, although the conduction velocities obtained by the two methods differ
considerably. Most clinical studies use bipolar stimulation (Kimura 1989b). As the
current flows between anode and cathode, negative charges that accumulate under the
cathode depolarize the nerve. Conversely, at the same time, positive charges under the
anode hyperpolarize the nerve. In bipolar stimulation, an anodal conduction block is
avoided by placing the cathode closer to the recording site. An electromyographic
stimulator is used to regulate the amount of current that is administered to stimulate a
nerve. Constant-voltage stimulators are used to regulate the output in voltage, so that the
actual current varies inversely with the impedance of electrode, skin, and subcutaneous
tissues. In constant-current units, the voltage changes according to the impedance, so that

31

a specified amount of current reaches the nerve within certain limits of the skin’s
resistance (Kimura 1989b). Electric stimuli can be classified on the basis of the
magnitude of the evoked action potential. A threshold stimulus elicits a response in some,
but not all axons contained in the nerve. A maximal stimulus activates all groups of axons
and a further increase in stimulus intensity causes no additional increase in the amplitude
of the evoked potential.
Surface and needle electrodes can be used to record evoked muscle and nerve
potentials. Needle electrodes are preferred by some investigators to record sensory and
mixed nerve action potentials because the amplitude of the recorded potential increases
and the noise from the electrode tissue surface is decreased by a factor of two to three
times over surface electrodes (Rosenfalck 1978). Ground electrodes are usually placed
subcutaneously between stimulating and recording electrodes.
The potentials assessed during electromyographic procedures range in amplitude
from microvolts to millivolts and an amplifying system using a storage oscilloscope or an
electromyographic computer is usually required to record them (Kimura 1989b).
The most important parameters obtained by electromyographic diagnostic
techniques include latency, amplitude of the evoked compound action potential, and
conduction velocity. Latency is referred to as the interval between the onset of a stimulus
to a nerve and the onset of the evoked response. Sensory nerve latency is only dependent
on nerve conduction properties, whereas motor latency includes neuromuscular
transmission (Kimura 1989b). The conduction velocity is the speed of propagation of an
action potential along a nerve or muscle fiber (Kimura 1989b). For a nerve trunk, the
maximum conduction velocity is calculated from the latency of the evoked potential at
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maximal or supramaximal intensity of stimulation at two points. The distance between
these two points (between stimulation and recording electrodes or between two different
sets of recording electrodes along the nerve trunk) is the conduction distance and is
divided by the difference between the corresponding latencies (conduction time) to obtain
the conduction velocity (Kimura 1989b). The calculated velocity represents the
conduction velocity of the fastest fibers and is expressed in meters per second (m/s). The
compound nerve action potential is the summation of nearly synchronous nerve fiber
action potentials recorded from a nerve trunk (Kimura 1989b). It is produced by direct or
indirect stimulation of the nerve and its amplitude is measured from the most positive to
the most negative peak. Under standardized circumstances, shape and amplitude of an
evoked compound action potential can be indicative of axonal damage or dysfunction in a
specific subset of nerve fibers (Kimura 1989b).
The validity of a calculated nerve conduction velocity depends on a variety of
technical factors and influences from the subject. Accuracy in determining the latencies
and the correct conduction distance are most imperative to obtain correct measurements.
Other sources of error associated with the technique include incorrect triggering of the
stimulus, poorly defined takeoff of the evoked response, inappropriate stimulus strength,
and inaccurate calibration (Kimura 1989b; Simpson 1964). In people, nerve conduction is
faster at warmer body temperatures (De Jesus et al. 1973). Alterations in nerve
conduction velocities related to limb temperatures were also identified in horses (Wheeler
1989). In people, both motor and sensory nerve fibers have furthermore been shown to
conduct substantially more slowly in legs than in arms, which has been associated with a
longer overall length of the nerves (Campbell et al. 1981; Kimura 1989b). One study

33

comparing horses and ponies demonstrated a consistent inverse relationship between
sensory nerve conduction velocities and animal height and nerve segment length (Blythe
et al. 1988).
A clear association between age and conduction velocities has been demonstrated
in people. Nerve conduction velocities nearly double their values between birth and 3 to 5
years of age, thereby paralleling the process of advancing myelination (Thomas and
Lambert 1960). As a function of age and growth in length, both motor and sensory nerve
conduction velocities tend to slightly increase in the upper limb and decrease in the lower
limb in later childhood and adolescence from age 3 to 19 years of age (Lang et al. 1985).
Conduction velocities begin to decline after 30 to 40 years of age, but the values normally
change by less than 10 m/s at 60 years of age (Taylor 1984). Studies in horses revealed an
increase of sensory nerve conduction velocity over the first year of life followed by a
subsequent decrease in older horses (Wheeler 1990).
The type of electromyographic abnormality is usually indicative of a specific kind
of lesion in the affected nerve. Substantial slowing in conduction velocity implies
demyelination of the sensory nerve fibers, whereas axonal damage with loss of continuity
and Wallerian degeneration of the distal nerve segment (axonotmesis) results in reduced
amplitude of the CAP with stimulation distal or proximal to the site of the lesion, or even
total loss of response (Kimura 1989b).
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CHAPTER 3
FUNCTIONAL AND MORPHOLOGICAL CHANGES IN PALMAR DIGITAL
NERVES FOLLOWING NON-FOCUSED EXTRACORPOREAL SHOCK WAVE
APPLICATION IN HORSES
3.1

Introduction
Extracorporeal shock wave therapy (ESWT) is a newly adapted treatment

modality used to treat musculoskeletal disorders in horses (McClure and Merritt 2003).
Various case series report successful treatment of soft tissue and bone disorders such as
proximal suspensory desmitis (Boening et al. 2000; Crowe et al. 2002), dorsal metacarpal
disease (Palmer 2002), navicular disease (Baer et al. 2001; Garcia Lineiro and
Echezzareta 2001), and osteoarthritis of the tarsometatarsal and distal intertarsal joints
(McCarrol and McClure 2000) with ESWT in horses. Although there is a paucity of
controlled studies and the specific mechanism by which shock waves affect tissues still
need to be elucidated, ESWT has become increasingly popular in equine practice.
Extracorporeal shock waves (ESW) are pressure gradient waves with a rise time
of 5 to 10 ns and a peak pressure of up to 100 megapascals (MPa), followed by a rapid
fall to negative pressure before returning to baseline in a total pulse time of
approximately 300 ns (Sturtevant 1996). Wave energy is released at interfaces of tissues
that have different acoustic impedances, resulting in compression and shear loads on the
surface of the material with the greater impedance value. These loads result in a process
called cavitation via development and collapse of microscopic gas bubbles. The
collapsing gas bubbles invert and a small jet of liquid impinges on the surface of the
material with greater impedance, thereby generating extremely high localized stresses
(Sturtevant 1996).
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Two fundamentally different techniques are used to generate ESW. Focused
shock wave generators were originally developed for the non-invasive destruction of
urinary calculi in people (Chaussy et al. 1980) and were later adapted to treat a variety of
musculoskeletal disorders (Haupt 1997; Rompe et al. 2001). Focused shock wave
generators initiate a pressure wave within a fluid medium and the wave is focused by
reflection within the generator toward a focal point in the patient (Sturtevant 1996). Nonfocused shock waves or radial pressure waves are generated by mechanical concussion.
They are characterized by lower energies, a slower rise time than focused waves, and a
negative component that is of the same order as the positive component. Their maximum
wave energy is observed at the applicator-skin interface and declines rapidly in
proportion to the distance from the generator (McClure and Merritt 2003).
Treatment with both focused and non-focused ESW has been reported to cause
analgesia. This analgesic effect is most likely independent of any other potential
beneficial effects on tissue healing and is observed rapidly after treatment. Clinical case
studies in man (Haupt 1997; Rompe et al. 2001) and horses (Boening et al. 2000;
McCarrol and McClure 2000) report substantial clinical improvement of various painful
orthopedic conditions without concurrent radiographic changes.
Analgesia of an injured limb represents a concern in an equine athlete because it
disables protective limiting mechanisms and may place horses with predisposing lesions
at an increased risk of sustaining a catastrophic potentially career-ending or lifethreatening injury when exercised with altered peripheral pain perception. This has been
recognized by the equine industry and has led to the development of safety regulations
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concerning the use of ESWT prior to competition or training by racing jurisdictions and
the Federation Equine International (McClure and Merritt 2003).
Extracorporeal shock wave therapy does not appear to be used to specifically treat
peripheral nerves in man. In horses, nerves of the distal limb or structures in their
immediate proximity are often treated directly or indirectly in order to provide relief from
painful syndromes in the foot, such as navicular disease (Baer et al. 2001; Garcia Lineiro
and Echezzareta 2001). There are no reports regarding the effects of ESWT on function
and morphology of peripheral nerves in horses.
The objectives of this study were to demonstrate the post-treatment analgesic
effect of ESWT by comparing sensory nerve conduction velocities (SNCV) in treated and
untreated peripheral nerves in vivo and to document morphologic changes in ESWTtreated nerve segments by histology and transmission electron microscopy (TEM) after
palmar digital neurectomy. It was hypothesized that a single treatment with non-focused
ESW applied directly over a peripheral nerve would result in decreased SNCV and
noticeable morphologic changes.
3.2

Materials and Methods

3.2.1

Animals
The study was approved by the Institutional Animal Care and Use Committee of

the Louisiana State University. A total of six horses were used in. Two Quarterhorses and
four Thoroughbred horses (4 geldings, 2 mares) with mean bodyweight of 522 kg (range
464 to 584 kg) and mean age of 14 years (range 5 to 17 years) were evaluated. Prior to
inclusion in the study, animals were clinically evaluated and determined to be free of
lameness. Horses were selected from a pool of animals used for research; individual
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housing was provided at a nearby research facility. All horses were fed a routine
complete pelleted diet and had free access to water.
3.2.2

Extracorporeal Shock Wave Therapy
All six horses were treated with non-focused ESW on day 0 of the study. Prior to

application of the ESW regimen, each horse was sedated with detomidine hydrochloridea
(0.02 mg/kg of body weight, IV) and butorphanol tartrateb (0.02 mg/kg of body weight,
IV). The hair on the palmar pastern of both front limbs was clipped and after application
of a coupling gel provided by the manufacturer, 2,000 pulses with a non-focused shock
wave generatorc were applied over the medial palmar digital nerve of the left forelimb.
The regimen was administered at a frequency of 240 pulses/min., with a machine
pressure of 0.25 MPa, using a 15-mm diameter applicator head. The same treatment was
then administered to the left lateral palmar digital nerve. No treatment was administered
to the right forelimb. The animals were returned to their stalls and daily hand-grazing was
provided until subsequent experimental procedures.
3.2.3

Sensory Nerve Conduction Velocity Measurements
Three groups of two horses each were evaluated at 3, 7, and 35 days following

ESW application, respectively. The animals were sedated with xylazine hydrochlorided
(0.5 mg/kg of body weight, IV) and butorphanol tartrateb (0.02 mg/kg of body weight,
IV) and general anesthesia was induced with ketamine hydrochloridee (2 mg/kg of body
weight, IV) and diazepamf (0.15 mg/kg of body weight, IV). Horses were placed in right
lateral recumbency and anesthesia was maintained with isofluraneg and oxygen in a semiclosed system. The pastern area and fetlock of both front limbs were aseptically prepared
and draped, and a lateral abaxial 3-cm incision was made along the deep digital flexor
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tendon in the mid-pastern area. The lateral palmar digital nerve was carefully isolated. A
second 1-cm incision was made abaxially at the level of the lateral proximal sesamoid
bone and the nerve was isolated at this site. A pair of sterile needle electrodes was placed
directly into the nerve at the distal incision (stimulating electrodes) and at the proximal
incision (recording electrodes). A ground electrode was placed dorsally into the skin
between the stimulating and recording electrodes (Figure 3.1). The stimulating electrode
was activated by a stimulator from an electromyography systemh (Figure 3.2). The
recording and ground electrodes were connected to the preamplifier of the
electromyographic recorder. The distance between stimulation and recording electrodes
was measured with a sterile measuring tape and entered into the system computer. Square
wave stimuli of 100 µs at 1 Hz were generated by the stimulator at various voltage
settings until a visible compound action potential (CAP) was recorded by the recording
electrodes and displayed on the system monitor (Figure 3.3). An average of 10 responses
per nerve was recorded and measurements in each nerve were conducted in duplicate to
demonstrate reproducibility. Sensory nerve conduction velocity (SNCV) in m/s was then
calculated by the system computer and the average of both measurements for each nerve
was recorded. Subsequently, the left medial and right medial palmar digital nerves were
approached similarly through medial abaxial incisions and SNCV was measured as
described above.
3.2.4

Palmar Digital Neurectomy
Immediately after the SNCV measurements, a 4-cm long segment of the palmar

digital nerve was resected and divided transversely with a sharp scalpel blade.
Representative sections were placed in 10% neutral-buffered formalin for histological
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evaluation and in primary fixative for transmission electron microscopy (1.25%
glutaraldehyde and 2% formaldehyde in 0.1M cacodylate buffer). The incisions were
closed with single interrupted skin sutures, using size 2-0 nylon suturei and bandaged.

Figure 3.1 - Photograph obtained during sensory nerve conduction velocity
measurements in the left lateral palmar digital nerve in a horse under general anesthesia.
The foot of the animal is draped off on the left side of the photo. Needle electrodes in
contact with the nerve can be observed in the distal (S = stimulating electrodes) and
proximal (R = recording electrodes) incisions.

Figure 3.2 - Position of the electrodes placed over the palmar digital nerves of
horses for sensory nerve conduction velocity measurements. S = stimulating electrode, R
= recording electrode, G = ground electrode, EMG = electromyography system, STIM =
electromyographic stimulator.
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After recovery from anesthesia, the horses were returned to their stalls. The
incision sites were kept bandaged until suture removal at two weeks after surgery. No
complications from the surgery were observed.
3.2.5 Histological Examination
Longitudinal and transverse sections of harvested nerve segments were fixed in
10% neutral-buffered formalin, routinely embedded in paraffin, cut at a thickness of 4 µm
on a rotary microtome,j and stained with hematoxylin and eosin (H&E) and luxol fast
blue (LFB). Morphologic changes were described and each nerve was assigned a
subjective histological score. Changes were described as mild (grade 1), moderate (grade
2), and severe (grade 3) when the number of affected nerve fibers was less than 10%,
between 10% and 40%, and more than 40%, respectively, in the examined sections.
Sections with no microscopic findings were assigned grade 0. The pathologist was blind
to the origin of the sample (treated vs. control nerves).
3.2.6

Transmission Electron Microscopy
Representative 3-mm2 transverse sections of excised nerve segments were washed

twice for 15 minutes in 0.1 mol/L sodium cacodylate containing 5% (W/V) sucrose. The
buffer wash was followed by post-fixation in 1% OsO4 in distilled water for 1 hour. After
several washes with distilled water, the nerve sections were stained overnight in 0.5%
(W/V) uranyl acetate in distilled water. The samples were then dehydrated in graded
ethanol solutions of increasing concentrations of 30%, 50%, 70%, 95% and 100%,
infiltrated with Poly/Bed 812,k and polymerized. Polymerized blocks were sectioned into
0.1-µm sections on an ultramicrotome.l The sections were stained with uranyl acetate and
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lead citrate, and examined using a transmission electron microscope.m The investigator
was blind to the origin of the sample (treated vs. control nerves).
3.2.7

Data Analysis
SNCV was considered continuous and the proportional difference in SNCV for

treated lateral and medial nerves, compared with control nerves within each horse, was
analyzed using a mixed effect linear model that accounted for random variance of horse
and limb, nested within time points. Ad-hoc comparisons were made within each nerve
and across treated nerves at each time point, maintaining type I error at 0.05. Thus, where
significance was determined, the p-value was set at ≤ 0.05, unless specified. A software
programn was used for analysis.
3.3

Results

3.3.1

Sensory Nerve Conduction Velocities
Velocities for treated and control nerves for each horse were summarized (Table

3.1). Careful surgical exploration and identification of the palmar digital nerves prior to
needle placement for stimulating and recording electrodes resulted in reliable and
reproducible SNCV measurements (Figure 3.3). Non-focused ESW caused a significant
decrease in SNCV in all treated nerves, compared with control nerves, at days 3 and 7. A
significant decrease in SNCV was also observed in treated medial but not lateral nerves at
day 35. There was no difference in the magnitude of decrease between treated medial and
lateral nerves on days 3 and 7.
3.3.2 Histological Examination
Varying degrees of segmental axonal swelling were the only histological change
observed. Swollen axonal segments had a pale, fine granular texture and were often
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Figure 3.3 - Compound action potential (CAP) recorded from a palmar digital
nerve of a horse after electrical stimulation. O = onset, P = peak, T = through. Arrow =
stimulus artifact.
Table 3.1 - Mean (individual values) of sensory nerve conduction velocities (m/s)
and individual subjective histological severity scores in palmar digital nerves of horses
treated with non-focused extracorporeal shock waves at 3,7, and 35 days after treatment.
SNCV = sensory nerve conduction velocity, HSS = histological severity score, LL = left
lateral palmar digital nerve, LM = left medial palmar digital nerve, RM = right medial
palmar digital nerve (untreated control). There was no difference in magnitude of the
decrease of SNCV for LL and LM nerves at days 3 and 7. Within each time point, “a”
denotes a significant decrease in SNCV compared to controls (RM).
Day post treatment

Nerve
LL

3

LM
RM
LL

7

LM
RM
LL

35

LM
RM
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SNCV
32.45a
(32.7, 32.2)
32.15a
(34.9, 30.4)
48.2
(49.9, 46.5)
37.0a
(39.1, 34.9)
32.26a
(34.9, 30.4)
60.25
(61.1, 59.4)
51.95
(61.7, 42.2)
37.9a
(37.4, 38.4)
43.35
(44.7, 42.0)

HSS
0, 2
2, 1
2, 0
2, 2
3, 3
2, 2
0, 0
2, 1
2, 1

Figure 3.4 - Photomicrograph of a longitudinal section of the left medial palmar
digital nerve of a horse at 7 days after treatment with non-focused ESW (grade 3
histological severity score). Note the fine granular texture in swollen axonal segments
(arrow) and the decreased cellularity of Schwann cells. Similar changes were observed in
treated nerves and untreated control nerves. Bar = 50 µm, luxol fast blue stain.

Figure 3.5 - Photomicrograph of a longitudinal section of the untreated right
medial palmar digital nerve (control nerve) of a horse at 3 days after treatment of the
nerves on the opposite limb with non-focused extracorporeal shock wave therapy (grade
0 histological severity score). No changes can be observed in myelinated (arrows) and
unmyelinated nerve fibers and in surrounding Schwann cells. Bar = 50 µm, hematoxylin
and eosin stain.
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localized at only one end of longitudinal sections. No cellular infiltrates or hemorrhage
was noted. Changes were observed in most treated and untreated nerve segments at 3, 7,
and 35 days after ESW application (Table 3.1). Severely affected nerve segments had a
decreased cellularity. The most severe changes were observed in left medial nerves at 7
days after ESW application (Figure 3.4). Some of the control nerve samples and some of
the treated nerve samples revealed no detectable changes (Figure 3.5).
3.3.3

Transmission Electron Microscopy
Transverse sections of treated and untreated nerve segments were examined.

Large- to medium-sized and small myelinated axons were observed. Non-myelinated
axons were surrounded by neurolemmacytes and embedded in a loose collagenous
endoneurium. In untreated nerves, concentric uniform myelin sheaths were evident in all
myelinated axons and no traumatic or inflammatory changes were observed (Figure 3.6).
Treated nerves at 3 (Figure 3.7), 7 (Figure 3.8) and 35 (Figure 3.9) days after ESWT
revealed extensive separation and disruption between the different layers of the myelin
sheath in large- to medium-sized myelinated axons, but no changes were observed in
small myelinated and non-myelinated axons. As with untreated nerves, no traumatic or
inflammatory changes were observed.
3.4

Discussion
This study revealed that a single application non-focused ESW over a peripheral

nerve results in a considerable decrease in conduction velocity and in separation and
disruption of the layers of the myelin sheath in large- to medium-sized myelinated axons.
A significant proportional difference in SNCV of ESW-treated versus untreated control
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Figure 3.6 - Photomicrograph obtained by transmission electron microscopy of a
transverse section through an untreated control nerve. Large- to medium-sized (dark
arrowheads) and small (light arrowheads) myelinated axons and numerous unmyelinated
axons (dark arrows) can be observed. Bar = 10 µm.
nerves was observed at 3 and 7 days following ESW treatment. Treated medial, but not
lateral, nerves also had a significantly decreased SNCV at 35 days following ESW
application.
It is believed that the absence of electrophysiologic changes in treated lateral
nerves at 35 days after treatment is most likely attributable to a lack of precision during
application of the ESW regimen and that the effects of ESW application on conduction
in peripheral nerves could most likely last beyond the follow-up period of the present
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Figure 3.7 - Photomicrograph obtained by transmission electron microscopy of a
transverse section through the left medial palmar digital nerve of a horse at 3 days after
treatment with non-focused extracorporeal shock wave therapy. There is separation
between the myelin layers in large-to medium-sized myelinated axons (dark arrowheads).
No changes can be observed in small myelinated axons (light arrowheads) and
unmyelinated axons (dark arrows). Bar = 10 µm.
study. Transmission electron microscopy consistently revealed separation and disruption
of the layers of the myelin sheath of large- to medium-sized myelinated axons in treated
nerves.
Histology revealed varying degrees of axonal swelling and cytoplasmic
dissolution with a fine granular texture in both treated and control nerve samples at all
time points. The histological changes have therefore to be considered artifacts that
occurred most likely during the sensory SNCV measurements or during the subsequent
palmar digital neurectomy.
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Figure 3.8 - Photomicrograph obtained by transmission electron microscopy of a
transverse section through the left medial palmar digital nerve at 7 days after treatment
with non-focused extracorporeal shock wave therapy. Severe disruption is evident in the
myelin sheath of large- to medium-sized myelinated axons (dark arrowheads). There are
no changes in small myelinated (light arrowheads) and unmyelinated axons (dark
arrows). Bar = 10 µm.
Results of nerve conduction studies closely parallel the structural abnormalities of
the nerve and depend on the type and degree of nerve damage. Partial demyelination and
traumatic damage to the myelin sheath in myelinated axons has been shown to result in
an impaired saltatory conduction due to an increase in internodal capacitance and
conductance (Kimura 1989b). More local current is lost to charge the membrane
capacitance and by leakage through the internodal membrane before reaching the next
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Figure 3.9 - Photomicrograph obtained by transmission electron microscopy of a
transverse section through the left medial palmar digital nerve at 35 days after treatment
with non-focused extracorporeal shock wave therapy. Large- to medium-sized myelinated
axons (dark arrowheads) reveal similar changes as in Figure 3.8. There are no changes in
small myelinated fibers (light arrowheads) and unmyelinated fibers (dark arrows). Bar =
10 µm.
node of Ranvier. Thus, axons with a damaged myelin sheath characteristically exhibit
decreased conduction velocity and temporal dispersion (Kimura 1989b). Impaired nerve
conduction without actual structural damage to the axonal cytoplasm is referred to as
neuropraxia and represents the mildest form of peripheral nerve injury (Seddon 1943).
The electron microscopic findings could explain the decrease in SNCV values
obtained in shock wave-treated nerves in the present study.
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The lack of electron microscopic changes in unmyelinated and small-sized
myelinated axons in treated nerves was consistent and it may be speculated that these
structures are either too small or provide an insufficient local change in impedance for
ESW to exert their effects.
Lameness disorders represent a therapeutic challenge to the equine practitioner
who wants to provide pain relief, reinstitute athletic use of the horse, and minimize
economic loss while operating within ethical and regulatory constraints of modern
competition. This has led to a growing interest in new, alternative treatment modalities
that appear to result in an improved and accelerated healing process and a shorter
convalescence period. Extracorporeal shock wave therapy represents such a modality and
appears to be gaining interest and acceptance in the equine industry among veterinarians,
trainers and owners for therapy of selected orthopedic injuries in horses.
Shock wave-induced stimulation of bone and soft tissue healing has been
observed in man (Haupt 1997; Wild et al. 2000) and various animal species (Johannes et
al. 1994; McClure and Merritt 2003; Wang et al. 2002), however, the exact effects of
high pressure waves on tissues are not yet fully understood. Treatments with focused and
non-focused ESW also seem to cause a transient analgesic effect within treated areas,
apparently independent of any other beneficial effect on tissues (McClure and Merritt
2003). The exact mechanism of this analgesic effect is unknown. Haist and von KeitzSteeger (1995) postulated three hypotheses for how shock waves induce analgesia in
humans: 1) shock waves induce cell damage and the peripheral nociceptors can therefore
not build up a membrane potential sufficient to transmit pain signals; 2) the nociceptors
are overstimulated by shock waves and emit high frequency impulses to peripheral nerve
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fibers, which are suppressed by a gate control mechanism; and 3) shock wave-induced
pericellular free radicals induce the local release of unknown pain-suppressing substances
(Haist and von Keitz-Steeger 1995).
In man, the analgesic response following ESWT appears to be bimodal. An
immediate initial decrease in pain for 3 to 4 days is followed by a return of the pain and
then a second gradual reduction in pain that occurs over the ensuing 3 to 4 weeks (Ogden
and Ogden 2002). The initial response has been attributed to the direct effects of ESW on
nociceptors and impaired substance P synthesis; whereas the second phase of pain relief
was believed to result from a healing response associated with angiogenesis and tissue
matrix remodeling (Ogden and Ogden 2002). A similar bimodal analgesic response can
be observed clinically in horses undergoing ESWT to treat musculoskeletal disorders
(McClure and Merritt 2003).
Musculoskeletal activity without full perception of peripheral pain could
potentially place equine athletes with predisposing lesions at an increased risk of
sustaining career-ending or life-threatening injuries such as condylar fracture of the third
metacarpus or metatarsus, or breakdown injuries of the suspensory apparatus. This risk
has been recognized by the equine industry and strict regulations concerning the use of
ESWT before competitions have been issued by multiple racing jurisdictions and the
Federation Equine International (McClure and Merritt 2003).
It has been recommended to avoid large nerves, blood vessels, and active growth
plates when applying ESWT to horses (McClure and Merritt 2003). Because of the
anatomical proximity of the target tissues to these structures, nerve trauma, however,
cannot always be avoided, or it is occasionally even desired (Garcia Lineiro and
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Echezzareta 2001). In horses, the palmar digital nerves may be treated directly or
indirectly when ESWT is used to treat disorders in the foot, such as navicular disease
(Baer et al. 2001; Garcia Lineiro and Echezzareta 2001). Extracorporeal shock wave
therapy does not appear to be used to specifically treat peripheral nerves in humans.
This study does not propose a conclusive explanation for the analgesic effect
observed subsequent to ESWT in horses; however, it supports the premise that ESW
cause damage to peripheral nerves resulting in slower conduction velocities and
potentially impaired perception of peripheral pain.
Morphological and functional changes associated with neuropraxia are reversible
over time (Kimura 1989b). Repeated application of ESWT, however, may cause more
extensive damage to exposed peripheral nerves and may result in prolonged or permanent
alterations in nerve conduction. Renal damage following extracorporeal shock wave
lithotripsy (ESWL) of nephroliths in dogs has been shown to be cumulative depending on
dose (voltage and number of shock waves) and frequency (number of shock waves per
second) of the administered regimen (Lingeman et al. 1989; Newman et al. 1987). An
experimental study also revealed dose-dependent morphological damage in the Achilles
tendon of rabbits after application of ESW (Rompe et al. 1998). It may be speculated that
administration of a greater total dose regimen of ESW may have resulted in prolonged
duration of impaired nerve conduction and more extensive morphological damage in
treated peripheral nerves.The duration of morphological nerve damage and impaired
nerve conduction was not assessed beyond 35 days in the present study. The results of
this study indicate that further research would be necessary to assess the effects of non-
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focused extracorporeal shock waves on peripheral nerves after a longer time period and
after multiple treatments.
In conclusion, direct treatment of palmar digital nerves in horses with a single
application of non-focused ESW resulted in a decrease of nerve conduction velocity and
distinct alterations in the myelin sheath of large- and medium-sized myelinated axons.
Although the small sample size of the present study limits the ability to draw a strong
conclusion and despite the fact that the results do not provide a conclusive explanation
for the analgesic effect observed in a clinical situation, cautious use of this treatment
regimen is recommended in equine athletes before training or competition.
3.5

Product Information

a

Dormosedan, Pfizer, Inc., New York, NY.
Torbugesic, Fort Dodge Animal Health, Fort Dodge, IA.
c
Swiss ColorClast® Vet, EMS Electro Medical Systems, Dallas, TX.
d
Xylaxine 100 Injection, The Butler Company, Columbus, OH.
e
Ketaset, Fort Dodge Animal Health, Fort Dodge, IA.
f
Diazepam Injection, Abbott Laboratories, North Chicago, IL.
g
IsoFlo, Abbott Laboratories, North Chicago, IL.
h
Cadwell Sierra EMG/EP, Cadwell Laboratories, Kennewick, WA.
i
Ethicon, Johnson & Johnson, Somerville, NJ.
j
Shandon AS325, Shandon Products, Pittsburgh, PA.
k
Poly/Bed 812, Polyscience, Inc., Warrington, PA.
l
MT-XL, RMC Products by Boeckeler Instruments, Inc., Tucson, AZ.
m
Zeiss (LEO) EM-10C, Oberkochen, Germany.
n
PROC MIXED, SAS V8.0, SAS Institute, Inc., Cary, NC.
b
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CHAPTER 4
EVALUATION OF THE LOCAL ANALGESIC EFFECT AFTER NONFOCUSED EXTRACORPOREAL SHOCK WAVE APPLICATION TO THE
THIRD METACARPAL BONE IN HORSES
4.1

Introduction
Periostitis and stress fractures of the dorsal cortex of the third metacarpal bone

represent conditions that are often observed in young fast-gaited performance horses at
two to three years of age (Bertone 2002). This disease complex is referred to as dorsal
metacarpal disease (DMD) and is believed to occur because of a failure of the adaptive
response to altered biomechanical stresses that arise from high-speed work (Bertone
2002). Racing Thoroughbreds have the greatest prevalence of DMD, but young Quarter
Horses and occasionally racing Standardbreds can also be affected (Bertone 2002).
Conventional treatment of DMD includes combinations of stall rest, altered
training regimens, and systemically administered non-steroidal anti-inflammatory drugs
(NSAIDs), percutaneous periosteal scraping, and osteostixis. Alternative treatment
modalities, such as cryotherapy (Montgomery et al. 1981), and more recently,
extracorporeal shock wave therapy (Palmer 2002; Scheuch et al. 2000), have also been
reported for the treatment of DMD. In a clinical report on 50 Thoroughbred racehorses
with DMD that were unresponsive to conventional treatment and were treated with
pneumatically generated non-focused extracorporeal shock wave therapy (ESWT), 40
horses (80%) resumed speed work without recurrence of lameness or other clinical signs
associated with DMD after three treatments at three-week intervals (Palmer 2002). In
another case series, 10 horses with dorsal or palmar metacarpal cortical stress fractures
were treated with one to three applications of focused ESWT administered under
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ultrasonographic control (Scheuch et al. 2000). Ninety days after treatment, eight of ten
horses had returned to racing or training and six were pain-free and/or revealed
radiographic signs of fracture healing (Scheuch et al. 2000). Despite the lack of reliable
controls, these reports suggest that ESWT may be useful for treatment of DMD.
Extracorporeal shock waves are acoustic pressure gradient waves that are used to
treat a variety of musculoskeletal disorders in people and animals. Although first
introduced for non-invasive treatment of urolithiasis in man (Chaussy et al. 1980), ESW
were subsequently investigated for their effect on wound healing (Haupt and Chvapil
1990) and their osteogenic potential (Ikeda et al. 1999; Johannes et al. 1994). Humans are
currently treated with ESWT for a variety of conditions including fracture non-unions
(Haupt 1997; Valchanou and Michailov 1991) and painful soft tissue syndromes such as
plantar calcaneal spurs (Rompe et al. 2003) and tennis elbow (Rompe et al. 2001).
Several clinical investigations in horses reported promising results in the treatment of a
variety of disorders such as bone spavin (McCarrol and McClure 2000), stress fractures
(Scheuch et al. 2000), high suspensory desmitis (Boening et al. 2000; Crowe et al. 2002)
and navicular disease (Baer et al. 2001; Garcia Lineiro and Echezzareta 2001). Horses are
often treated using non-focused ESW or radial pressure waves that are characterized by
their distinct physical characteristics including lower wave energies, a slower rise time,
and their inferior penetration into the patient’s body compared to focused ESW (McClure
and Merritt 2003). However, beneficial effects in treatment of musculoskeletal disorders
with non-focused ESW have been reported in people (Gremion et al. 2001; Lohrer et al.
2001a; Lohrer et al. 2001b) and horses (Boening et al. 2000; Crowe et al. 2002; Palmer
2002).
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Although the precise mechanism by which ESW exert their effect on tissues are
currently not known, transient local analgesia of the treated areas has been observed in
people (Ogden and Ogden 2002) and horses (McClure and Merritt 2003). This analgesic
effect is likely to be independent of any other beneficial effect on healing of injured
structures and could place performance horses with predisposing bone and soft tissue
lesions at risk of sustaining a life- or career-threatening injury when exercised too
strenuously after application of shock wave therapy. Recognition of these safety concerns
has resulted in the development of regulations concerning the use of ESWT prior to
competition and training by racing jurisdictions and the Federation Equine International
(McClure and Merritt 2003).
The purpose of this study was to evaluate the local cutaneous analgesic effect of
ESW in the distal limb of horses. It was hypothesized that a single treatment with nonfocused ESW applied dorsally to the third metacarpal bone would induce a transient local
analgesic effect and that altered peripheral pain perception could be assessed by
evaluating the response to a standardized thermal cutaneous pain stimulus. The specific
objective was to compare the latency of onset, magnitude and duration of analgesia in
metacarpal areas treated with non-focused ESW to non-treated areas.
4.2

Materials and Methods

4.2.1

Animals
The study was approved by the Institutional Animal Care and Use Committee of

the Louisiana State University. Twelve adult horses from the institutional research herd
were used in the study: Five Quarter Horses (three geldings, two mares), six
Thoroughbreds (four geldings, two mares) and one Arabian with a mean age of 14 years
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(range five to 19 years). Prior to inclusion in the study, all animals were clinically
evaluated and determined to be free of lameness and apparent abnormalities in their
metacarpal bones. Individual housing was provided at a nearby research facility and all
horses were fed a routine complete pelleted diet and had free access to water.
4.2.2

Extracorporeal Shock Wave Therapy
Prior to ESW application, each horse was sedated with detomidine hydrochloridea

(0.02 mg/kg of body weight, IV) and butorphanol tartrateb (0.02 mg/kg of body weight,
IV) and the hair on the medial, lateral and dorsal aspect of both metacarpi was clipped.
One forelimb of each animal was randomly assigned to be treated. The skin of five
circular areas (1.5 cm diameter) on the treated metacarpus (lateral-mid-diaphysis = area
1; dorsal-mid-diaphysis = area 2; medial-mid-diaphysis = area 3; dorsal-proximal
diaphysis = area 4; dorsal-distal diaphysis = area 5) and on one area on the control limb
(dorsal metacarpal mid-diaphysis = area 6) of each animal were darkened with a black
ink felt pen to improve light absorption for assessment of the limb withdrawal reflex
latency (LWRL). After application of a coupling gel provided by the manufacturer, 2,000
pulses with a non-focused ESW generatorc were applied over each of the three middiaphyseal circular areas of the treatment limb (areas 1, 2, 3). The regimen was
administered at a frequency of 240 pulses/min., with a machine pressure of 0.25 MPa,
using a 15-mm diameter applicator head. The proximal and distal diaphyseal areas on the
treated limb (areas 4 and 5) and the mid-diaphyseal area on the opposite limb (area 6)
served as controls (Figure 4.1).
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Figure 4.1 - Areas for evaluation of the limb withdrawal reflex latency (LWRL)
on the third metacarpal bones of horses treated with non-focused extracorporeal shock
waves. A = shock wave-treated limb. B = untreated control limb. 1, 2, 3 = treated areas.
4, 5, 6 = untreated control areas.
4.2.3

Assessment of the Limb Withdrawal Reflex Latency
The degree of cutaneous analgesia caused by non-focused ESW was quantified by

assessment of alterations in a nociceptive threshold, using a focused light beam as a
stimulus. Briefly, horses were led into the testing area and a focused beam of light of a
standardized intensityd was emitted from a distance of 20 cm onto the target areas on the
third metacarpal bones. The time from stimulus when the light beam was emitted until
withdrawal of the limb was observed, and this response was designated as the limb
withdrawal reflex latency (LWRL). Baseline measurements were obtained in both treated
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and control areas prior to application of the ESW regimen. Following treatment of the
designated areas, LWRL was assessed in random order in all areas of both limbs every
two hours for 12 hours, followed by measurements every eight hours for 48 hours after
treatment. Each LWRL measurement was repeated three times in each area.
4.2.4

Data Analysis
Time to withdrawal from the light source was considered continuous, and

determined to follow a normal distribution, using the Shapiro-Wilk test with rejection of
the null hypothesis of normality at p≤ 0.05. Results were summarized as mean ± SEM.
Using each horse as its own control (blocking by horse), the effects of treatment and time
were evaluated, using a mixed effect linear model accounting for the random variance of
horses and repeated measurements on each horse. Where there were significant main and
interaction effects, selected multiple comparisons were made to determine the between
treatment effects at various time points and the effect of time within treatments. A
software programe,f was used for analysis.
4.3

Results
Application of non-focused ESW was well tolerated by all horses. Eight of the 12

horses developed mild to moderate swelling and skin abrasions over the treated areas.
These changes were observed immediately after the end of ESW application.
The LWRL responses were similar in all treated and control areas over time with
a significant decrease noted at most areas and time points compared with baseline
measurements.
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Table 4.1 - Mean ± (SEM) limb withdrawal reflex latency values of horses after application of non-focused shock waves to the
metacarpus. Areas 1, 2, 3 = treated areas on mid-diaphysis of the treated limb; areas 4, 5 = untreated control areas on the treated limb;
area 6 = mid-diaphyseal area on the opposite limb (untreated control). Within each treatment area (row), “a” denotes means that are
significantly (p ≤ 0.05) different from the baseline measurements. Within each time point (column), “b” indicates means that are
significantly (p ≤ 0.05) different from area 6 (untreated control).
2

4

6

Hours after treatment
8
10

Area

Baseline

1

13.41 (1.71)

10.76 (0.89)a

8.96 (0.54)a

7.76 (0.55) a

7.32 (0.35) a, b

6.93 (0.35) a b

6.32 (0.45) a, b

9.36 (1.18)

6.68 (0.41) a

8.11 (1.00) a, b

2

15.18 (1.65)

11.73 (1.36)

10.46 (0.82) a

8.27 (0.84) a

7.64 (0.59) a, b

7.36 (0.62) a

6.96 (0.44) a, b

9.43 (1.14) a

7.06 (0.37) a

8.06 (1.15) a, b

3

17.66 (2.54)

12.11 (0.10)a

9.66 (0.92) a

8.52 (0.74) a

8.05 (0.44) a, b

7.32 (0.46) a

7.82 (0.59) a, b

11.80 (2.70) a

7.08 (0.60) a

8.95 (1.02) a

4

13.47 (1.28)

10.89 (0.87)

9.17 (0.75) a

8.30 (0.88) a

7.28 (0.59) a, b

7.18 (0.55) a b

8.13 (0.46) a

9.13 (1.20) a

6.89 (0.48) a

9.44 (1.16)

5

14.79 (1.59)

11.70 (0.42)

10.04 (0.80) a

8.26 (1.13) a

8.92 (0.80) a

8.05 (0.67) a

7.48 (0.62) a b

8.53 (1.14) a b

9.44 (2.01) a

9.99 (1.27) a

6

17.26 (2.45)

12.43 (0.72)a

10.84 (1.20) a

9.36 (0.75) a

11.06 (1.38) a

9.53 (0.83) a

10.06 (0.82) a

14.55 (1.72)

9.44 (0.64) a

13.21 (1.79)
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12

20

28

48

Between point comparisons at different times after treatment revealed no significant
difference between areas during baseline LWRL measurements, and at 2, 4, 6 and 28
hours after ESW application (Table 4.1). There was a significant decrease in LWRL at
most areas on the treated limb, compared with the control area on the opposite limb (area
6), at 8, 10, 12, 20 and 48 hours after treatment.
4.4

Discussion
Non-focused ESW applied to the third metacarpal bone of horses had no

noticeable effect on LWRL in the present study. A significant decrease in LWRL was
observed over time, but there was no difference between treated and control areas on
ESW-treated metacarpi and control areas on the opposite limbs. Because swelling and
skin abrasions were observed in several horses, a local inflammatory response secondary
to treatment-induced trauma could potentially have overwhelmed any local cutaneous
analgesic effect. However, considering the similarity of the findings in treated and
untreated areas over time, it appears more likely that no local analgesia resulted from
ESW application. Tissue trauma and inflammation after ESW application may have
induced hypersensitivity in all testing sites of the treated limbs. This could be somewhat
corroborated by the significant decrease of LWRL in some areas of the treated limb,
compared with the control area on the opposite limb (area 6), at 8, 10, 12, 20 and 48
hours after treatment. Another explanation for the progressive decrease of LWRL in all
tested areas over time could be that the horses became conditioned to testing during the
study and that a painful thermal stimulus was anticipated. Other studies using the same
type of thermal stimulus to assess the analgesic effects of intravenously (Kamerling et al.
1985) and locally (Harkins et al. 1996; Lopez-Sanroman et al. 2003) administered drugs,

61

and to demonstrate local analgesia after acupuncture and electroacupuncture treatment
(Skarda et al. 2002) did not report conditioning of animals to the testing procedure.
Preventative measures, such as blindfolding the horses prior to testing (Lopez-Sanroman
et al. 2003) or intermittent use of an unfocused (sham) light source (Harkins et al. 1996)
have been used in some protocols, however, they were not implemented in the present
study.
The effect of ESW application to the third metacarpal bone on LWRL was not
assessed beyond 48 hours. This follow-up period was chosen based on clinical
observations in humans (Ogden and Ogden 2002) where the analgesic response appears
to be biphasic. An immediate initial improvement in clinical signs is normally followed
by a return of the pain at three to four days after treatment and then a second gradual
improvement over the ensuing 3 to 4 weeks. The initial response is believed to result
from the direct effects of shock waves on nociceptors and impaired substance P synthesis,
whereas the second phase of pain relief is believed to result from a healing response
associated with angiogenesis and tissue matrix remodeling (Ogden and Ogden 2002). A
study in sheep, however, failed to identify depletion of the neuropeptides substance P and
calcitonin gene-related peptide in the soft tissues overlying metacarpi after treatment with
focused or non-focused ESW (McClure et al. 2003).
The results of the present study are contradictory to observations made in another
investigation where cutaneous analgesia of the overlying skin during the first 72 hours
after application of focused or non-focused ESW to the third metacarpal bone in horses
was observed (McClure et al. 2003). In that study, however, cutaneous sensation was
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assessed only once every 24 hours and an electric stimulus was used to test for local
cutaneous analgesia (McClure et al. 2003).
In people, shock wave therapy is often used to provide relief in painful conditions
at the soft tissue – bone interface such as tennis elbow, calcific shoulder tendonitis, or
plantar calcaneal spurs (Haupt 1997; Rompe et al. 1996; Rompe et al. 2001). The rapid
improvement of clinical signs after ESWT is usually not accompanied by concurrent
radiographic changes and has been attributed to an analgesic effect that appears to be
independent of the healing response in tissues (Haupt 1997). Similar observations were
made in horses with osteoarthritis of the distal intertarsal and tarsometatarsal joints.
Eighty percent of the horses improved at least one lameness grade and 18% were
completely sound at 90 days after a single treatment with focused ESWT. No concurrent
radiographic changes were observed in any of the horses (McCarrol and McClure 2000).
Haist and von Keitz-Steiger proposed three hypotheses for shock wave-induced
analgesia in people: 1) shock waves induce cell damage and the peripheral nociceptors
can therefore not build up a membrane potential to transmit pain signals; 2) the
nociceptors are over-stimulated by shock waves and emit high frequency impulses to
peripheral nerve fibers, which are suppressed by a gate control mechanism; and 3) shock
wave-induced pericellular free radicals induce the local release of unknown painsuppressing substances (Haist and von Keitz-Steeger 1995).
Direct effects of ESW on peripheral nerves could contribute substantially to
regional analgesia after ESWT. A study in isolated frog sciatic nerves revealed repetitive
generation of action potentials during application of ESW (Schelling et al. 1994).
Although this in vitro mechanism may not be applicable to the distal equine limb in vivo
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(McClure et al. 2003), it is possible that ESW could over-stimulate peripheral sensory
nerve fibers and that signal transmission could be impaired by modulation via a gate
control-like mechanism (Haist and von Keitz-Steeger 1995). A study in horses revealed a
significant decrease in sensory nerve conduction velocity in palmar digital nerves after
direct treatment with non-focused ESW compared with untreated control nerves (Bolt et
al. 2003). Transmission electron microscopy of treated nerves showed disruption and
separation within the myelin sheaths of large- to medium-sized myelinated axons (Bolt et
al. 2003). The lack of a cutaneous analgesic effect in the present study could therefore
possibly be explained by the absence of peripheral nerves with large myelinated axons in
the treated areas.
It has been recommended to avoid peripheral nerves, large blood vessels and
growth plates when applying ESWT to horses (McClure and Merritt 2003). However,
peripheral nerves are often directly targeted when ESW are used to treat conditions in the
distal limb such as navicular disease (Garcia Lineiro and Echezzareta 2001). Although
clinical improvement of navicular disease after ESWT has been observed (Baer et al.
2001; Garcia Lineiro and Echezzareta 2001), an experimental study in horses failed to
identify local cutaneous analgesia in the heel area following ESW application to the
palmar digital nerves in the pastern (McClure et al. 2003).
In conclusion, the findings of the present study show that a single application of
non-focused ESW had no noticeable cutaneous analgesic effect in the equine metacarpus.
These findings, in light of clinical observations of post-treatment analgesia in people and
horses, results of other experimental studies (McClure et al. 2003), and distinct changes
in directly treated peripheral nerves after ESW application (Bolt et al. 2003), indicate that
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this treatment modality should be used cautiously when treating equine athletes in
training or before competition.
4.5

Product Information

a

Dormosedan, Pfizer, Inc., New York, NY.
Torbugesic, Fort Dodge Animal Health, Fort Dodge, IA.
c
Swiss DolorClast® Vet, EMS Electro Medical Systems, Dallas, TX.
d
Kamerling SG, Weckman TJ, DeQuick DJ, et al. A method for studying cutaneous pain
perception and analgesia in horses. J Pharmacol Methods 1985;13:267-274.
e
PROC UNIVARIATE, SAS V8.0, SAS Institute, Inc., Cary, NC.
f
PROC MIXED, SAS V8.0, SAS Institute, Inc., Cary, NC.
b
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CHAPTER 5
SUMMARY
In the first study, application of 2,000 pulses of non-focused extracorporeal shock
waves (ESW) to the palmar digital nerves of horses in the pastern area resulted in
decreased sensory nerve conduction velocities (SNCV) and caused distinct morphologic
changes at 3,7 and 35 days after treatment. Morphologic changes detected by
transmission electron microscopy consisted of an extensive separation and disruption
between the different layers of the myelin sheath in large- to medium-sized myelinated
axons. These alterations are compatible with decreased SNCV assessed prior to surgical
removal of the nerves for morphologic evaluation. No changes were detected in small
myelinated and non-myelinated axons. Microscopic evaluation revealed varying degrees
of axonal swelling and cytoplasmic dissolution with a fine granular texture in both treated
and untreated nerves at all time points. The microscopic changes have therefore to be
considered artifacts that occurred most likely during the sensory SNCV measurements or
during the subsequent palmar digital neurectomy.
In the second study, no significant difference in nociceptive threshold was found
between areas of the metacarpus treated with 2,000 pulses of non-focused ESW and
untreated control areas on the same and on the contralateral metacarpus when cutaneous
sensation was assessed with a focused light source. Limb withdrawal reflex latency
(LWRL) responses in all horses were comparable in treated and control areas over time
with a significant decrease noted at most sites and times compared with baseline
measurements. Between area comparisons at different times after treatment revealed a
decrease in LWRL between most sites of the treated limb and the untreated control area
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of the contralateral metacarpus. These findings may indicate conditioning of the animals
to the LWRL testing method, although the decrease in LWRL between most areas of the
treated metacarpus and the non-treated area of the opposite metacarpus may be due to a
treatment-induced hypersensitivity of the entire dorsal metacarpal surface following
application of non-focused ESW.
Although the findings of these studies do not provide a conclusive explanation for
the analgesic effect observed after clinical application of ESW, they provide some
evidence that ESW can induce distinct electrophysiologic and morphologic changes when
they are administered directly to peripheral nerves. Further investigations are required to
better understand the analgesic affect after application of ESW in horses and to evaluate
the effects of repeated ESW applications on function and morphology of peripheral
nerves.
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